Creatine Peptides: Research & Evidence
Established EvidencePublished research, clinical trial data, and evidence grading for Creatine Peptides across studied indications.
Back to Creatine Peptides overviewResearch Summary
Creatine monohydrate is one of the most extensively studied supplements with 300+ RCTs and 22 meta-analyses demonstrating consistent 5-15% strength improvements. However, creatine peptide forms specifically have only 10-15 comparative RCTs and have not demonstrated a clear absorption or efficacy advantage over standard creatine monohydrate. Evidence for cognitive, anti-aging, or non-athletic applications remains limited.
Evidence by Indication (4 indications)
| Indication | Tier | Trials | Summary |
|---|---|---|---|
| High-intensity exercise performance | Tier A | 300 | Extensive RCT evidence for creatine monohydrate; 5-15% strength improvement |
| Muscle mass (resistance training) | Tier A | 50 | Consistent ~2kg fat-free mass increase with training |
| Creatine peptide vs monohydrate | Tier C | 15 | No clear advantage for peptide form over monohydrate |
| Cognitive function | Tier C | 8 | Minimal effect in healthy adults per 2022 meta-analysis |
Graded using our evidence tier methodology.
Citations (5 sources)
- 1. Effect of creatine supplementation on body composition and performance: a meta-analysis Review
Branch JD (2003), International Journal of Sport Nutrition and Exercise Metabolism
- 2. Creatine supplementation and fat-free mass Study
Rawson ES, et al. (2007), Journal of Strength and Conditioning Research
- 3. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation Review
Kreider RB, et al. (2017), Journal of the International Society of Sports Nutrition
- 4. Creatine supplementation and muscle mass in the elderly Study
Lanhers C, et al. (2015), Journal of Cachexia, Sarcopenia and Muscle
- 5. Creatine and strength: meta-analysis of 22 systematic reviews Review
Multiple authors (2023), Sports Medicine